CD40LG and measles: When the assay was repeated in a larger panel of acute measles samples (validation panel), we observed elevated levels of anti-measles VL dIgA compared to controls, albeit lower than anti-measles VL dIgA reactivities measured in the earlier commercial panel or using anti-measles IgM (Fig. 2).